Biometric Security Holdings Limited - Limited company - abbreviated - 11.0.0
Biometric Security Holdings Limited - Limited company - abbreviated - 11.0.0
BIOMETRIC SECURITY HOLDINGS LIMITED |
ABBREVIATED UNAUDITED ACCOUNTS |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
BIOMETRIC SECURITY HOLDINGS LIMITED (REGISTERED NUMBER: 06270962) |
CONTENTS OF THE ABBREVIATED ACCOUNTS |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
Page |
Company Information | 1 |
Abbreviated Balance Sheet | 2 |
Notes to the Abbreviated Accounts | 3 |
BIOMETRIC SECURITY HOLDINGS LIMITED |
COMPANY INFORMATION |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
BIOMETRIC SECURITY HOLDINGS LIMITED (REGISTERED NUMBER: 06270962) |
ABBREVIATED BALANCE SHEET |
31 DECEMBER 2013 |
2013 | 2012 |
Notes | £ | £ |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 3 |
Share premium |
Profit and loss account | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved and authorised for use by the Board of Directors on |
BIOMETRIC SECURITY HOLDINGS LIMITED (REGISTERED NUMBER: 06270962) |
NOTES TO THE ABBREVIATED ACCOUNTS |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
1. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
The principal accounting policies of the company remain unchanged and are set out below. The |
directors have reviewed the accounting policies adopted and consider them to be the most |
appropriate. |
The directors believe that the Company will continue as a going concern having considered the |
financial prospects for the Company over the next 12 months including reviewing the potential for |
securing sources of additional revenue. |
The Company's ability to continue on a going concern basis depends on the ability to support the |
operations of the group companies. There remains an uncertainty surrounding the Group's ability to |
secure additional forecast revenues. The Directors have drawn up Group forecasts under multiple |
scenarios in order to manage future cashflow. There is however, no guarantee that new revenue |
sources will be secured. |
The cost saving programme, which commenced in 2008, continued during the period. Plans have been |
prepared which incorporate these and other identified changes to the cost structure appropriate under |
a range of potential trading scenarios. |
The directors consider it appropriate to prepare the financial statements on a going concern basis. |
Biometric Security Holdings Limited has indicated its willingness to continue its support for it's |
subsidiary going forward. |
Accounting convention |
The financial statements have been prepared under the historical cost convention and in accordance |
with the Financial Reporting Standard for Smaller Entities (effective April 2008). |
Exemption form preparing consolidated financial statements |
The financial statements contain information about Biometric Security Holdings Limited as an |
individual company and do not contain consolidated financial information as the parent of a group. The |
company has taken the option under Section 398 of the Companies Act 2006 not to prepare |
consolidated financial statements. |
Exemption from preparing a cash flow statement |
Exemption has been taken from preparing a cash flow statement on the grounds that the company |
qualifies as a small company. |
Deferred tax |
Deferred tax is recognised on all timing differences where the transactions or events give the company |
an obligation to pay more tax in the future, or a right to pay less tax in the future has occurred by the |
balance sheet date. Deferred tax assets are recognised when it is more likely than not that they will be |
recovered. Deferred tax is measured using rates that have been enacted or substantively enacted by |
the balance sheet date. |
The accumulated losses have resulted in significant tax allowable losses being built up which can be |
offset against future trading profits. At present the directors are uncertain as to whether sufficient |
profits will be realised against which to offset these losses and accordingly no deferred tax asset has |
been recognised in the financial statements. |
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at |
the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of |
exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at |
the operating result. |
BIOMETRIC SECURITY HOLDINGS LIMITED (REGISTERED NUMBER: 06270962) |
NOTES TO THE ABBREVIATED ACCOUNTS - continued |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
1. | ACCOUNTING POLICIES - continued |
Financial instruments |
Financial liabilities and equity instruments are classified according to the substance of the contractual |
arrangements entered into. An equity instrument is any contract that evidences a residual interest in |
the assets of the entity after deducting all of its financial liabilities. |
Where the contractual terms of share capital do not have any terms meeting the definition of a |
financial liability then this is classed as an equity instrument. Dividends and distributions relating to |
equity instruments are debited direct to equity. |
Compound instruments |
Compound instruments comprise both a liability and an equity component. At date of issue, the fair |
value of the liability component is estimated by calculating the present value of the future stream of |
cash flows, discounted by using the prevailing market interest rate for a similar debt instrument. The |
liability component is accounted for as a financial liability. The residual is the difference between the |
net proceeds of issue and the liability component (at time of issue) and is the equity component, which |
is accounted for as an equity instrument. |
The interest expense on the liability component is calculated applying the effective interest rate for the |
liability component of the instrument. The difference between this amount and any repayments is |
added to the carrying amount of the liability in the balance sheet. |
2. | FIXED ASSET INVESTMENTS |
Investments |
other |
than |
loans |
£ |
COST |
At 1 January 2013 |
and 31 December 2013 |
PROVISIONS |
At 1 January 2013 |
and 31 December 2013 |
NET BOOK VALUE |
At 31 December 2013 |
At 31 December 2012 |
The company's investments at the balance sheet date in the share capital of companies include the |
following: |
Country of incorporation: |
Nature of business: |
% |
Class of shares: | holding |
£ | £ |
Aggregate capital and reserves | (10,555,887 | ) | (10,015,286 | ) |
Loss for the year | (540,600 | ) | (543,039 | ) |
BIOMETRIC SECURITY HOLDINGS LIMITED (REGISTERED NUMBER: 06270962) |
NOTES TO THE ABBREVIATED ACCOUNTS - continued |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
2. | FIXED ASSET INVESTMENTS - continued |
Country of incorporation: |
Nature of business: |
% |
Class of shares: | holding |
£ | £ |
Aggregate capital and reserves | (3,224,773 | ) | (2,816,483 | ) |
Loss for the year | (408,290 | ) | (655,235 | ) |
3. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 2013 | 2012 |
Value: | £ | £ |
20,805,759 | Ordinary | 1.000p | 208,058 | 2,676 |
34,954,359 | Ordinary 'A' | 0.909p | 317,735 | - |
406,855 | Growth | 1.000p | 4,069 | 4,069 |
- | 'A' Preferred | 1.000p | - | 17,768 |
- | 'B' Preferred | 1.000p | - | 12,037 |
- | 'D' Preferred | 1.000p | - | 257,620 |
529,862 | 294,170 |
The Ordinary share, the Ordinary 'A' share, and the 'A', 'B', 'C' and 'D' Preferred shares rank pari passu |
in most respects however the Preferred shares also entitle the holders to a degree of priority on a |
liquidation or other return of capital, in accordance with the Company's Articles of Association. The |
Growth shares do not have voting rights or participate in a distribution of assets. Under certain |
circumstances and where the company has sufficient value, the growth shares convert into Ordinary |
shares and assume the same rights as other Ordinary shares. |
Full details of the growth criteria can be found in the Company's Articles of Association. The directors |
consider that it is appropriate to disclose these shares as equity instruments. |
On 22 February 2013, 6,011,501 'D' Preferred shares of 1p each were alloted and fully paid from new |
investment for £0.0582217 per share. |
On 26 June 2013, 31,773,511 'D' Preferred shares of 1p each were converted to 34,954,359 Ordinary |
'A' shares of 0.909p each. |
On 26 June 2013, 1,776,770 'A' Preferred shares of 1p each were converted to 1,776,770 Ordinary |
shares of 1p each. |
On 26 June 2013, 1,203,670 'B' Preferred shares of 1p each were converted to 1,203,670 Ordinary |
shares of 1p each. |
On 10 July 2013, 15,985,494 Ordinary shares of 1p each were alloted and fully paid from new |
investment for £0.0985891 per share. |
On 30 October 2013, 1,572,181 Ordinary shares of 1p each were alloted and fully paid from new |
investment for £0.0985891 per share. |
BIOMETRIC SECURITY HOLDINGS LIMITED (REGISTERED NUMBER: 06270962) |
NOTES TO THE ABBREVIATED ACCOUNTS - continued |
FOR THE YEAR ENDED 31 DECEMBER 2013 |
4. | ULTIMATE CONTROLLING PARTY |
The company was under the control of the board of directors throughout the current period by means |
of their shareholdings and directorship. There was however no overall controlling party during the |
period. |